| 溶解性 | DMSO 38 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
| 存贮条件 | 储存温度-20°C |
| 备注 | BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM. Phase 2. |
| 生化机理 | BMS-707035 is an HIV-1 integrase (IN) inhibitor. BMS-707035 was scheduled to be evaluated in a Phase II study to assess the antiretroviral activity, safety, pharmacodynamics, and pharmacokinetics in 50 HIV-infected subjects using a 10-day randomized, double-blind, placebo-controlled, ascending multiple-dose study design. |
| 别名 | 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin;4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin |
BMS-707035,可逆的HIV-1整合酶（IN）抑制剂
BMS-707035 （订货以英文为准）
编号：B126158
CAS号：729607-74-3
分子式：C17H19FN4O5S
分子量：410.42
| 产品名称 | BMS-707035 |
| 中文名称 | BMS-707035,可逆的HIV-1整合酶（IN）抑制剂 |
| CAS号 | 729607-74-3 |
| 分子式（M.F.） | C17H19FN4O5S |
| 分子量（M.W.） | 410.42 |
| 储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 500.00
sh6786-10mL
¥ 420.00
01484972-4L
¥ 1520.00
BWY0821011-1mL
¥ 259.00
sh24567-1个
¥ 5212.00
2106-0016-1箱
¥ 3406.00
2106-0002 -1箱
¥ 3289.00
2106-0001-1箱
¥ 510.00
P9157-50T-PKG-5T
党沛 
